CKD: Pharmacotherapy in a House of Mirrors

References 

1. Guidance for Industry: Pharmacokinetics in patients with impaired renal function—Study design, data analysis, and impact on dosing and labeling. Available at: http://www.asn-online.org/policy_and_public_affairs/docs/Draft%20FDA%20Guidance%20for%20PK%20Studies%20in%20Renal%20Failure%203%2010.pdf. Accessed June 7, 2010
2. Letter from ASN to FDA dated 5/21/10. Available at: http://www.asn-online.org/policy_and_public_affairs/docs/ASN%20Letter%20on%20FDA%20PK%20Draft%20Guidelines.pdf. Accessed June 7, 2010
3. KDIGO Controversies Conference: Drug Prescribing in Kidney Disease: Initiative for Improved Dosing, Baltimore, MD, May 2010. Available at: http://www.kdigo.org/meetings_events/drug_Prescribing_in_KD-Initiative_for_Improved_Dosing.php. Accessed June 10, 2010
4. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010;303:235–241
   • CrossRef
5. Kaplan B, Mason NA, Shimp LA, et al. Chronic hemodialysis patients. Part I: Characterization and drug-related problems. Ann Pharmacother. 1994;28:316–318
   • MEDLINE
6. Institute for Healthcare Improvement: Prevent Adverse Drug Events (Medication Reconciliation). Institute for Healthcare Improvement (IHI) website. Available at: http://www.ihi.org/IHI/Programs/Campaign/ADEsMedReconciliation.htm. Accessed June 9, 2010
7. Institute for Safe Medication Practices: ISMP Medication Safety. Institute for Safe Medication Practices website. Available at: http://www.ismp.org/newsletters/acutecare/articles/20050421.asp. Accessed June 9, 2010
8. The Joint Commission: Sentinel Event Alert #35. Using medication reconciliation to prevent errors. The Joint Commission website. Available at: http://www.jointcommission.org/SentinelEvents/SentinelEventAlert/sea_35.htm. Accessed June 9, 2010